Trevi Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TRVI and other ETFs, options, and stocks.About TRVI
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of Haduvio to treat serious neurologically mediated conditions. It includes treatment of chronic pruritus associated with prurigo nodularis and chronic cough in patients with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in patients with Parkinson’s disease.
CEOJennifer L. Good
CEOJennifer L. Good
Employees26
Employees26
HeadquartersNew Haven, Connecticut
HeadquartersNew Haven, Connecticut
Founded2011
Founded2011
Employees26
Employees26
TRVI Key Statistics
Market cap1.32B
Market cap1.32B
Price-Earnings ratio-25.81
Price-Earnings ratio-25.81
Dividend yield—
Dividend yield—
Average volume1.33M
Average volume1.33M
High today$10.98
High today$10.98
Low today$10.44
Low today$10.44
Open price$10.46
Open price$10.46
Volume977.91K
Volume977.91K
52 Week high$11.83
52 Week high$11.83
52 Week low$2.36
52 Week low$2.36
Stock Snapshot
The current Trevi Therapeutics(TRVI) stock price is $10.86, with a market capitalization of 1.32B. The stock trades at a price-to-earnings (P/E) ratio of -25.81.
On 2025-11-05, Trevi Therapeutics(TRVI) stock traded between a low of $10.44 and a high of $10.98. Shares are currently priced at $10.86, which is +4.0% above the low and -1.1% below the high.
Trevi Therapeutics(TRVI) shares are trading with a volume of 977.91K, against a daily average of 1.33M.
In the last year, Trevi Therapeutics(TRVI) shares hit a 52-week high of $11.83 and a 52-week low of $2.36.
In the last year, Trevi Therapeutics(TRVI) shares hit a 52-week high of $11.83 and a 52-week low of $2.36.
Analyst ratings
100%
of 12 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own TRVI. This list is generated using Robinhood data, and it’s not a recommendation.